Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP12 | P39900 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | VHL | P40337 | 1/20 | 0.44 |
| ▸ | ELOC | Q15369 | 1/20 | 0.44 |
| ▸ | ELOB | Q15370 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL91640 | 0.81 | VHL (0.51) | MMP12MAPTVHLELOCELOB | |
| SCHEMBL11873711 | 0.81 | ELANE (0.51) | MAPTKDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL86191 | 0.81 | ELANE (0.51) | MAPTKDM4ESMN1; SMN2KMT2AMEN1 | |
| SCHEMBL86749 | 0.81 | MAOB (0.54) | MMP12MAPTVHLELOCELOB | |
| SCHEMBL11866133 | 0.77 | KDM4E (0.46) | MMP12MAPTKDM4EKMT2AMEN1 | |
| SCHEMBL11863037 | 0.77 | AKR1B1 (0.58) | MMP12MAPTVHLELOCELOB | |
| SCHEMBL11872200 | 0.76 | MAPT (0.43) | MMP12MAPTKDM4ENPSR1KMT2A | |
| SCHEMBL4135391 | 0.73 | METAP1 (0.50) | HTTMETAP1TDP1AGTR1 | |
| SCHEMBL11215973 | 0.72 | ELANE (0.67) | AGTR1 | |
| SCHEMBL11215991 | 0.72 | ELANE (0.67) | AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2053095-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2017-02-22 | — | — | EP | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| EP-2053095-A2 | Ink composition and inkjet recording method using the same | Fujifilm Corporation (JP) | 2009-04-29 | — | — | EP | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | RB1, IK, NOX1 | MMP12 3435/4885MAPT 2087/4885VHL 3930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.